Penumbra (PEN) Change in Account Payables (2014 - 2026)
Penumbra (PEN) posted quarterly Change in Account Payables of $1.4 million for Q2 2026, up 142.69% year-over-year from $571510.8 in Q2 2025, and down 84.53% quarter-over-quarter from $9.0 million in Q1 2026.
Penumbra (PEN) Change in Account Payables (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Change in Account Payables for 13 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Account Payables rose 142.69% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $16.9 million (up 451.04% YoY), while the FY2025 annual figure was $3.1 million, down 26.49% from the prior year.
- Change in Account Payables declined to $1.4 million in Q2 2026 per PEN's latest filing, from $9.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $9.0 million in Q1 2026 and bottomed at -$3.2 million in Q2 2025.
- Historically, Change in Account Payables has averaged $1.8 million across 5 years, with a median of $1.4 million in 2022.
- Annual changes were most pronounced in 2025 — Change in Account Payables sank 1248.06% — and 2026, when it soared 3672.11%.
- Penumbra's Change in Account Payables stood at $295000.0 in 2022, then slumped by 424.41% to -$957000.0 in 2023, then slumped by 94.67% to -$1.9 million in 2024, then surged by 343.59% to $4.5 million in 2025, then sank by 69.44% to $1.4 million in 2026.
- Business Quant data shows PEN's Change in Account Payables at $1.4 million in Q2 2026, $9.0 million in Q1 2026, and $4.5 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Penumbra | 12.78 Bn | 12.13 Bn | 264.94 Mn | 1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.39 Mn |
| Jun 30, 2026 | 1.39 Mn |
| Mar 31, 2026 | 8.97 Mn |
| Mar 31, 2026 | 8.97 Mn |
| Dec 31, 2025 | 4.54 Mn |
| Dec 31, 2025 | 4.54 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | -3.25 Mn |
| Jun 30, 2025 | -3.25 Mn |
| Mar 31, 2025 | -251,000.00 |
| Mar 31, 2025 | -251,000.00 |
| Dec 31, 2024 | -1.86 Mn |
| Dec 31, 2024 | -1.86 Mn |
| Sep 30, 2024 | 543,000.00 |
| Sep 30, 2024 | 543,000.00 |
| Jun 30, 2024 | 283,000.00 |
| Jun 30, 2024 | 283,000.00 |
| Mar 31, 2024 | 5.21 Mn |
| Mar 31, 2024 | 5.21 Mn |